01—Abstract
Summary
Summary of the 10-K/A filed March 14, 2005. Cited figures are marked; the original filing is the authoritative source.
Charles River Laboratories International, Inc. filed this Amendment No. 1 to its Form 10-K for the fiscal year ended December 25, 2004.
According to the explanatory note, the sole purpose of the amendment is to add the date, March 9, 2005, to the Report of Independent Registered Public Accounting Firm in Item 8. The original Form 10-K was filed with the SEC on March 9, 2005. The registrant is a Delaware corporation headquartered in Wilmington, Massachusetts, with common stock listed on the New York Stock Exchange.
The filing reports an aggregate market value of voting common stock held by non-affiliates of approximately $2,150,196,678a as of June 25, 2004, and 66,109,790 shares outstanding as of March 1, 2005. The auditor, PricewaterhouseCoopers LLP, issued an integrated audit opinion covering the 2004 consolidated financial statements, the financial statement schedule, and the effectiveness of internal control over financial reporting as of December 25, 2004. The auditor also covered the December 27, 2003 and December 28, 2002 consolidated financial statements.
The firm concluded that the company maintained effective internal control over financial reporting in all material respects, based on the COSO Internal Control framework. Management excluded Inveresk Research Group, Inc., which the company acquired in a purchase business combination during 2004, from its internal control assessment, and the auditor likewise excluded it from its audit.
The filing states that Inveresk's total assets and total revenues represent 67%b and 7.9%, respectively, of the related consolidated amounts for the year ended December 25, 2004. Part III information is incorporated by reference from the 2005 Proxy Statement for the annual meeting scheduled for May 9, 2005.
02—Key points
Key Highlights
- The amendment's only stated change is adding the March 9, 2005 date to the auditor's report in Item 8 of the Form 10-K for the fiscal year ended December 25, 2004.
- PricewaterhouseCoopers LLP issued an unqualified opinion that the 2004 consolidated financial statements present fairly, in all material respects, the company's financial position and results, and that internal control over financial reporting was effective as of December 25, 2004.
- The company acquired Inveresk Research Group, Inc. in a purchase business combination during 2004, and excluded it from both management's and the auditor's internal control assessments.
- Inveresk Research Group, Inc. accounted for 67% of the related consolidated total assets and 7.9% of consolidated total revenues for the year ended December 25, 2004.
- The aggregate market value of common stock held by non-affiliates was approximately $2,150,196,678 as of June 25, 2004.
- As of March 1, 2005, there were 66,109,790 shares of common stock outstanding, par value $0.01 per share, listed on the New York Stock Exchange.
- Part III information is incorporated by reference from the 2005 Proxy Statement for the annual meeting of stockholders scheduled for May 9, 2005.
03—Questions
Frequently Asked Questions
Why was this amended Form 10-K filed?
According to the explanatory note, the company filed this amendment to add the date, March 9, 2005, to the Report of Independent Registered Public Accounting Firm in Item 8. The amendment addresses that date and does not state any change to the financial information.
Who audited the company's 2004 financial statements, and what was the opinion?
PricewaterhouseCoopers LLP of Boston, Massachusetts audited the 2004 consolidated financial statements and the internal control over financial reporting. The firm stated that the financial statements present fairly, in all material respects, the company's financial position and results of operations and cash flows for the three years ended December 25, 2004. It also stated that the company maintained effective internal control over financial reporting as of that date.
How significant is the Inveresk Research Group acquisition to the company's reported results?
The filing states that Inveresk Research Group, Inc., acquired in 2004 in a purchase business combination, represents 67% of the related consolidated total assets and 7.9% of the related consolidated total revenues for the year ended December 25, 2004. Because it was acquired during the year, management and the auditor excluded it from the internal control assessment.
What was the company's equity market value and share count?
The aggregate market value of voting common stock held by non-affiliates was approximately $2,150,196,678 on June 25, 2004. As of March 1, 2005, there were 66,109,790 shares of common stock outstanding, with a par value of $0.01 per share.
04—Continue